Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-37807 in open-angle glaucoma or ocular hypertension
NCT00287521Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Nov 2005
- Primary completion
- Feb 2006
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AL-37807 in open-angle glaucoma (OAG) and ocular hypertension (4 arms), sponsored by Alcon Inc. Primary endpoint: Mean intra-ocular pressure change at 28 days. Started Nov 2005; status: completed.
02
Drugs
AL-37807
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00287521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287521.